Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma
| Status: | Completed |
|---|---|
| Conditions: | Healthy Studies, High Blood Pressure (Hypertension), Ocular |
| Therapuetic Areas: | Cardiology / Vascular Diseases, Ophthalmology, Other |
| Healthy: | No |
| Age Range: | 20 - Any |
| Updated: | 5/5/2014 |
| Start Date: | September 2013 |
| End Date: | August 2014 |
| Contact: | Alcon Call Center |
| Email: | alcon.medinfo@alcon.com |
| Phone: | 1-888-451-3937 |
Investigation of IOP Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma
The purpose of this study is to investigate IOP reduction efficacy of travoprost 0.004%
ophthalmic solution (TRAVATAN Z®) in subjects with normal tension glaucoma using TRAVATAN Z®
monotherapy.
ophthalmic solution (TRAVATAN Z®) in subjects with normal tension glaucoma using TRAVATAN Z®
monotherapy.
Inclusion Criteria:
- Diagnosis of normal tension glaucoma.
- Must sign an Informed Consent form.
- IOP within protocol-specified range.
- Other protocol-specified inclusion criteria may apply.
Exclusion Criteria:
- Pregnant and lactating women, or women who intend to become pregnant during the study
period.
- Advanced and serious glaucoma, as specified in protocol.
- Complicated chronic or recurrent uveitis, scleritis or corneal herpes.
- History of ocular trauma, intraocular surgery or laser surgery for the included eye.
- Ocular-infection and severe ocular complication.
- Best-corrected visual acuity (BCVA) worse than 0.2 decimal.
- Difficulty in conducting applanation tonometry for the included eye as determined by
the doctor.
- Severe or serious hypersensitivity to prostaglandin analogues or any ingredients used
in the study.
- Use of IOP lowering ophthalmic solutions other than TRAVATAN Z® or oral carbonic
anhydrase inhibitor (Diamox, etc.) during the study period.
- Use of any adrenocorticosteroids during the study period.
- Use of IOP lowering ophthalmic solution within the past 30 days.
- Regarded by doctor as not suitable for study participation.
- Other protocol-specified exclusion criteria may apply.
We found this trial at
1
site
Alcon Call Center Alcon is helping people see the world better through advanced surgical, pharmaceutical...
Click here to add this to my saved trials
